Literature DB >> 15034077

Mycobacterium tuberculosis resides in nonacidified vacuoles in endocytically competent alveolar macrophages from patients with tuberculosis and HIV infection.

Henry C Mwandumba1, David G Russell, Mukanthu H Nyirenda, Jennifer Anderson, Sarah A White, Malcolm E Molyneux, S Bertel Squire.   

Abstract

Alveolar macrophages (AM) are the first professional phagocytes encountered by aerosols containing infections in the lungs, and their phagocytic capacity may be affected by these infections or environmental particles. The aim of this study was to evaluate the innate endocytic and phagocytic properties of human AM obtained from patients with pulmonary tuberculosis and to characterize the vacuoles in which Mycobacterium tuberculosis bacilli reside in vivo. AM were obtained by bronchoalveolar lavage from patients with suspected tuberculosis and from asymptomatic volunteers (controls). Clinical case definitions were based on mycobacterial culture of respiratory specimens and HIV serology. To assess phagocytosis, endocytosis, and acidification of the endosomal system, AM were cultured with IgG-coated polystyrene beads, dextran, and a pH-sensitive reporter (3-(2,4-dinitroanilino)-3-amino-N-methyldipropylamine) and were evaluated by light and immunoelectron microscopy. Cells from 89 patients and 10 controls were studied. We found no significant difference between the two groups in the ability of AM either to ingest beads and dextran or to deliver them to acidified lysosomes. In AM from patients with tuberculosis, the bacilli were located in vacuoles that failed to accumulate endocytosed material and were not acidified. We concluded that AM from patients with tuberculosis and HIV infections were competent to endocytose and phagocytose material and to deliver the material to functional, acidified lysosomes. M. tuberculosis residing in these AM arrests the progression of their phagosomes, which fail to fuse with acidified lysosomes. This confirms, for the first time in humans with tuberculosis and HIV, the conclusions from previous animal and in vitro studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15034077     DOI: 10.4049/jimmunol.172.7.4592

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

Review 1.  Acid resistance in Mycobacterium tuberculosis.

Authors:  Omar H Vandal; Carl F Nathan; Sabine Ehrt
Journal:  J Bacteriol       Date:  2009-05-22       Impact factor: 3.490

2.  HIV-1 and the immune response to TB.

Authors:  Naomi F Walker; Graeme Meintjes; Robert J Wilkinson
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

3.  The ins and outs of the Mycobacterium tuberculosis-containing vacuole.

Authors:  David G Russell
Journal:  Cell Microbiol       Date:  2016-06-27       Impact factor: 3.715

Review 4.  Beyond macrophages: the diversity of mononuclear cells in tuberculosis.

Authors:  Smita Srivastava; Joel D Ernst; Ludovic Desvignes
Journal:  Immunol Rev       Date:  2014-11       Impact factor: 12.988

Review 5.  HIV and tuberculosis: a deadly human syndemic.

Authors:  Candice K Kwan; Joel D Ernst
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

6.  Role of protease inhibitor 9 in survival and replication of Mycobacterium tuberculosis in mononuclear phagocytes from HIV-1-infected patients.

Authors:  Zahra Toossi; Mianda Wu; Shigou Liu; Christina S Hirsch; Jessica Walrath; Marieke van Ham; Richard F Silver
Journal:  AIDS       Date:  2014-03-13       Impact factor: 4.177

Review 7.  Mycobacterium tuberculosis and the intimate discourse of a chronic infection.

Authors:  David G Russell
Journal:  Immunol Rev       Date:  2011-03       Impact factor: 12.988

8.  Infection of macrophages with Mycobacterium tuberculosis induces global modifications to phagosomal function.

Authors:  Maria Podinovskaia; Wonsik Lee; Shannon Caldwell; David G Russell
Journal:  Cell Microbiol       Date:  2013-01-09       Impact factor: 3.715

9.  Tuberculosis after one year of combination antiretroviral therapy in Nigeria: a retrospective cohort study.

Authors:  Maxwell O Akanbi; Chad J Achenbach; Joe Feinglass; Babafemi Taiwo; Adamu Onu; Mai T Pho; Oche Agbaji; Phyllis Kanki; Robert L Murphy
Journal:  AIDS Res Hum Retroviruses       Date:  2013-02-25       Impact factor: 2.205

10.  Isolation of Mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation.

Authors:  Kevin Pethe; Dana L Swenson; Sylvie Alonso; Jennifer Anderson; Carren Wang; David G Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.